|
| Status |
Public on Apr 01, 2011 |
| Title |
Gene Re-expression in Calu6 Tumors Following Epigenetic Therapy |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
|
| Summary |
Transciptional profiling of Calu6 tumors comparing 4 pooled untreated tumors to 5-azacytodine or 5-azacytodine + MS-275 (combined therapy) treated tumors
|
| |
|
| Overall design |
Three-condition experiment, untreated vs. 5-Azacytodine tumors, and untreated vs. 5-azacytodine + MS-275 tumors: 4 pooled untreated tumors; 4 5-Azacytodine treated, 4 5-Azacytodine + MS-275 treated. Study used a loop design with dye-swap.
|
| |
|
| Contributor(s) |
Belinsky SA, Picchi MA, Mitchell H |
| Citation(s) |
21224363 |
| Submission date |
Oct 15, 2010 |
| Last update date |
Feb 22, 2018 |
| Contact name |
Steven A Belinsky |
| E-mail(s) |
sbelinsk@lrri.org
|
| Phone |
5053489465
|
| Fax |
5053488567
|
| Organization name |
Lovelace Respiratory Research Institute
|
| Department |
Lung Cancer Program
|
| Lab |
Belinsky
|
| Street address |
2425 Ridgecrest Dr SE
|
| City |
Albuquerque |
| State/province |
NM |
| ZIP/Postal code |
87112 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL4133 |
Agilent-014850 Whole Human Genome Microarray 4x44K G4112F (Feature Number version) |
|
| Samples (9)
|
| GSM609192 |
Pool-cy5 vs. D38T2-cy3 (untreated vs. aza) |
| GSM609193 |
D38T2-cy5 vs. D42T12-cy3 (aza vs. aza) |
| GSM609194 |
D42T12-cy5 vs. D38T4-cy3 (aza vs. aza) |
| GSM609195 |
D38T4-cy5 vs. D42T5-cy3 (aza vs. aza) |
| GSM609196 |
D42T5-cy5 vs. E38T3-cy3 (aza vs. combined) |
| GSM609197 |
E38T3-cy5 vs. E34T1-cy3 (combined vs. combined) |
| GSM609198 |
E34T1-cy5 vs. E38T8-cy3 (combined vs. combined) |
| GSM609199 |
E38T8-cy5 vs. E42T5-cy3 (combined vs. combined) |
| GSM609200 |
E42T5-cy5 vs. Pool-cy3 (combined vs. untreated) |
|
| Relations |
| BioProject |
PRJNA132355 |
Less...
More...